A review of new science, in plain language

BMJ  ·  29 July 2026  ·  From issue 13

Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial

A blood thinner helped more migraine patients with a heart hole than a standard migraine drug did.

Ziping Li, Chuangshi Wang et al.

People with migraines often have a small hole between the heart's upper chambers. This trial tested if blood thinning drugs help these people more than a standard migraine drug does. A blood thinner called rivaroxaban helped more people cut their migraine days in half. It worked better than the usual drug, and no major bleeding happened during the 12 week test.

Integrity screen: passed (3 checks) Checked 10 September 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Five vetted papers in plain language, free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 13 15 papers
More from BMJ